PSMA PET-CT

for prostate cancer

  • Targeted PET imaging specific for prostate cancer
  • Provides information about tumour, nodal and metastatic disease
  • Fusion PET-MRI imaging is a one-stop shop for evaluation of prostate cancer evaluation
  • Over 60% of castrate resistant prostate cancers respond to radionuclide therapy with Lutetium-PSMA / alpha therapy with Actinium

Did you know ?
Prostate PET-CT is the most sensitive technique for identifying disease in biochemical recurrence